Combined effect of volumetric breast density and body mass index on breast cancer risk. Read more about Combined effect of volumetric breast density and body mass index on breast cancer risk.
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Read more about Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Validation of the breast cancer surveillance consortium model of breast cancer risk. Read more about Validation of the breast cancer surveillance consortium model of breast cancer risk.
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea. Read more about The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. Read more about Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up.
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Read more about A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Read more about Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.
Correction to: Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors. Read more about Correction to: Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.
Preoperative breast MRI and mortality in older women with breast cancer. Read more about Preoperative breast MRI and mortality in older women with breast cancer.
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Read more about Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics.
